Next Article in Journal
Making the Most of Complexity to Create Opportunities: Comprehensive Genomic Profiling and Molecular Tumor Board for Patients with Non-Small Cell Lung Cancer (NSCLC)
Next Article in Special Issue
PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for Immunotherapy
Previous Article in Journal
Paediatric Gliomas: BRAF and Histone H3 as Biomarkers, Therapy and Perspective of Liquid Biopsies
Previous Article in Special Issue
HER2-Positive Breast Cancer Patients with Pre-Treatment Axillary Involvement or Postmenopausal Status Benefit from Neoadjuvant Rather than Adjuvant Chemotherapy Plus Trastuzumab Regimens
 
 
Article

Article Versions Notes

Cancers 2021, 13(4), 608; https://doi.org/10.3390/cancers13040608
Action Date Notes Link
article xml file uploaded 4 February 2021 08:52 CET Original file -
article xml uploaded. 4 February 2021 08:52 CET Update https://www.mdpi.com/2072-6694/13/4/608/xml
article pdf uploaded. 4 February 2021 08:52 CET Version of Record https://www.mdpi.com/2072-6694/13/4/608/pdf
article html file updated 4 February 2021 08:53 CET Original file -
article html file updated 24 July 2022 14:00 CEST Update https://www.mdpi.com/2072-6694/13/4/608/html
Back to TopTop